These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23410072)

  • 21. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
    Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
    Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 24. Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens.
    Anugraha G; Madhumathi J; Jeya Prita PJ; Kaliraj P
    Eur J Pharmacol; 2015 Jan; 747():174-80. PubMed ID: 25514604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy.
    Zhang W; Wang L; Yang T; Liu Y; Chen X; Liu Q; Jia J; Ma G
    Pharm Res; 2015 Sep; 32(9):2837-50. PubMed ID: 26017300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
    Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
    Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
    J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective efficacy of PLGA microspheres loaded with divalent DNA vaccine encoding the ompA gene of Aeromonas veronii and the hly gene of Aeromonas hydrophila in mice.
    Gao S; Zhao N; Amer S; Qian M; Lv M; Zhao Y; Su X; Cao J; He H; Zhao B
    Vaccine; 2013 Nov; 31(48):5754-9. PubMed ID: 24012571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
    Eratalay A; Coşkun-Ari FF; Oner F; Ozcengīz E
    J Microencapsul; 2010; 27(1):48-56. PubMed ID: 19545223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant.
    Colonna C; Dorati R; Conti B; Caliceti P; Genta I
    Int J Pharm; 2013 Aug; 452(1-2):390-401. PubMed ID: 23707885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
    Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
    J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
    Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
    Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodegradable microspheres containing influenza A vaccine: immune response in mice.
    Hilbert AK; Fritzsche U; Kissel T
    Vaccine; 1999 Mar; 17(9-10):1065-73. PubMed ID: 10195616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.
    Hussain MJ; Wilkinson A; Bramwell VW; Christensen D; Perrie Y
    J Pharm Pharmacol; 2014 Mar; 66(3):358-66. PubMed ID: 24251796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice.
    Ali R; Kumar S; Naqvi RA; Sheikh IA; Rao DN
    Int Immunopharmacol; 2013 Jan; 15(1):97-105. PubMed ID: 23174507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-
    Roopngam P; Liu K; Mei L; Zheng Y; Zhu X; Tsai HI; Huang L
    Int J Nanomedicine; 2016; 11():5361-5370. PubMed ID: 27789948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.